看季报手头剩下现金不多,估计够烧10个月,可能有融资需要查看全文
黄野仁2019-03-19 21:12
$Aravive(ARAV)$
Key Study Results:">Key Study Results:
Increased serum and tumor GAS6 levels are associated with chemoresistance and decreased progression free survival (PFS) in patients with high-grade serous ovarian cancer undergoing neoadjuvant treatment.•...查看全文
$Aravive(ARAV)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-023724 Act: 34 Size: 90 KB 网页链接
$Aravive(ARAV)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000921895-24-000461 Act: 34 Size: 283 KB 网页链接
$Aravive(ARAV)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-030314 Act: 34 Size: 137 KB 网页链接
$Aravive(ARAV)$ 15-12G Securities registration termination [Section 12(g)] Accession Number: 0001437749-24-003421 Act: 34 Size: 10 KB 网页链接
$Aravive(ARAV)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000277 Act: 33 Size: 1 KB 网页链接
$Aravive(ARAV)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000275 Act: 33 Size: 1 KB 网页链接
$Aravive(ARAV)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000278 Act: 33 Size: 1 KB 网页链接
$Aravive(ARAV)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000276 Act: 33 Size: 1 KB 网页链接
$Aravive(ARAV)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000274 Act: 33 Size: 1 KB 网页链接
$Aravive(ARAV)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001437749-24-002454 Act: 33 Size: 24 KB 网页链接